@article{TAU154386,
author = {Youssef Garras and Daniah Alsaadi and Ned Kinnear and Derek Hennessey},
title = {Bacillus Calmette-Guérin therapy in the management of upper tract urothelial carcinoma in-situ: a systematic review},
journal = {Translational Andrology and Urology},
volume = {15},
number = {5},
year = {2026},
keywords = {},
abstract = {Upper urinary tract carcinoma in-situ (UUT-CIS) is an aggressive disease traditionally managed with radical nephroureterectomy (RNU), often resulting in loss of renal function. Topical Bacillus Calmette-Guérin (BCG) therapy has been explored as a kidney-sparing alternative, although evidence remains limited and heterogeneous. This review aimed to synthesise oncological and safety outcomes of topical BCG therapy for UUT-CIS.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/154386}
}